I saw 94-year-old Mrs. M in an outreach clinic. Mrs. M was being treated for hypertension.
She was enjoying a healthy life until 6 months previous when she was diagnosed with
hypertension on a routine physical examination. She was told that her blood pressure
was mildly elevated. Anti-hypertensive therapy was initiated with a β-adrenergic receptor
blocking agent. On each of the subsequent visits, a new anti-hypertensive agent was
added to her drug regimen, and eventually, to achieve the ideal control of blood pressure,
her anti-hypertensive drug regimen consisted of a maximum dose of a β-adrenergic receptor
blocking agent, a high dose of a calcium-channel blocker, and a high dose of an α-adrenergic
receptor blocking agent, along with a high dose of a diuretic agent.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Accepted:
October 29,
2001
Received:
July 2,
2001
Identification
Copyright
© 2002 Elsevier Science Inc. Published by Elsevier Inc. All rights reserved.
